The regulatory role of DPP4 in atherosclerotic disease. - Wikidata - wikimedia - TriplyDB

The regulatory role of DPP4 in atherosclerotic disease.

The regulatory role of DPP4 in atherosclerotic disease.

http://www.wikidata.org/entity/Q33805518

about

Active Stromal Cell-Derived Factor 1α and Endothelial Progenitor Cells are Equally Increased by Alogliptin in Good and Poor Diabetes Control.The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.

P2860

Q47131763-6CBDFEA0-3257-47D2-8D3C-EE204C473D92 Q52718518-37E025F4-3230-47E0-BD5D-FA9988E2AB8F

P2860

The regulatory role of DPP4 in atherosclerotic disease.

http://www.wikidata.org/entity/Q33805518

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

The regulatory role of DPP4 in atherosclerotic disease.

@ast

The regulatory role of DPP4 in atherosclerotic disease.

@en

type

label

The regulatory role of DPP4 in atherosclerotic disease.

@ast

The regulatory role of DPP4 in atherosclerotic disease.

@en

prefLabel

The regulatory role of DPP4 in atherosclerotic disease.

@ast

The regulatory role of DPP4 in atherosclerotic disease.

@en

P1433

Q33805518-FBE7561B-2694-483F-A9BD-4A7562DD8139

P1476

Q33805518-7B34895B-D6CB-4F07-9144-952705A185ED

P2093

Q33805518-152D9073-01E4-4A97-979A-A10D844732AA

Q33805518-2DCE17AC-8FED-4D3A-BA76-263138AFABC1

Q33805518-BE89CC1C-B615-4C11-9817-5253F2AF29FF

Q33805518-EE1E75B0-163F-4DCA-B96E-E41F2DDC1C79

P275

Q33805518-7AEB1388-7528-4878-974E-D95B5432E282

P2860

Q33805518-06745B70-0F34-4E98-B5D0-02765DEE8A39

Q33805518-07DF2D30-5281-4F52-9759-6D890268A6D0

Q33805518-09CB01A8-9F98-4926-843F-F14B13208DEC

Q33805518-0B4BF25D-33BC-4864-960E-5811D6DEA7E6

Q33805518-12BFB8CD-A019-4867-B5A6-92B29AD13657

Q33805518-16B5A550-E30D-4BDD-8980-F23C21B56886

Q33805518-1837CB46-954E-49ED-A307-6EEEA91AC03F

Q33805518-1C6A8F8F-AACE-433D-BF20-DECCFA78741E

Q33805518-1C93FDA0-5739-4B39-AB88-11E139DCED1A

Q33805518-1CC190D3-654C-4AA6-8DC5-DAEBFC9DDDAB

P2888

Q33805518-3A21619D-E815-44D2-ADA9-186AFF9A3EE8

P304

Q33805518-45F7D07E-7264-4BEF-AC08-B9DA877F0736

P31

Q33805518-105CDDF2-BCEE-491E-8B00-1F727B17D5A3

P356

Q33805518-A659E9C1-5CD8-4165-B4DF-0EC5059A3118

P407

Q33805518-7145F0BF-0C80-434D-9F9E-E4963E8C9BA4

P433

Q33805518-EEE907CB-D35E-4482-AAFD-F4F857A5F5DC

P478

Q33805518-0D40E7CC-6C91-427B-9DA6-2DBF0C863757

P50

Q33805518-1F465027-2BB2-4BA7-A924-F6449C885AA4

P5008

Q33805518-8057EDB1-A8E6-4868-8650-A6720B3C445D

P577

Q33805518-1D96F495-B178-46BF-ACC4-F608EC7DC854

P6179

Q33805518-05883BF5-5FD0-4B68-8A60-304A49F9A9FF

P698

Q33805518-9A0363C3-7EE5-415C-86A3-E2DE1E366CAC

P921

Q33805518-60D6A0A4-60BA-4887-94BD-A04014CD547D

Q33805518-671573EB-1418-41CF-8E08-2BA90779D470

Q33805518-8591B1BB-4F5F-49E1-830D-1FD742760371

P932

Q33805518-B0699C81-9D1D-4F9D-8AF2-51513E972BD1

P356

S12933-017-0558-Y

P1433

Cardiovascular Diabetology

P1476

The regulatory role of DPP4 in atherosclerotic disease

@en

P2093

Chang Xia

http://www.w3.org/2001/XMLSchema#string

Lihua Duan

http://www.w3.org/2001/XMLSchema#string

Sanjay Rajagopalan

http://www.w3.org/2001/XMLSchema#string

Xiaoquan Rao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Atherosclerosis

Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies

Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes

Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

P2888

s12933-017-0558-y

P304

76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0558-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086040404

http://www.w3.org/2001/XMLSchema#string

P698

28619058

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

atherosclerosis

P932

5472996

http://www.w3.org/2001/XMLSchema#string